-
EC grants label extension approval for Astellas' Xtandi for use in additional recurrent early prostate cancer treatment setting
25 Apr 2024 06:20 GMT
… of their cancer spreading or dying compared to those treated with … their cancer spreading and early death. The patient community welcomes any … 3 will die as a result of their metastatic prostate cancer. The EMBARK …
-
Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer - Beyond the Abstract
24 Apr 2024 20:47 GMT
… of prostate cancer, providers should balance the risk of death from prostate cancer against … other causes (non-prostate cancer mortality). Less … ,977 deaths, 86% of which were not due to prostate cancer). Median …
-
Masturbation can lower prostate cancer risk: expert
24 Apr 2024 19:40 GMT
… prostate cancer at bay. Prostate cancer is the second leading cause of cancer death … ejaculation can reduce prostate cancer by decreasing the … in 44 men will die of prostate cancer. auremar – stock. … ejaculation frequency and prostate cancer is not fully …
-
European Commission approves Astellas’ drug for expanded prostate cancer Treatment
24 Apr 2024 14:24 GMT
… for advanced prostate cancer.
“Many men with hormone-sensitive prostate cancer undergo … cancer spreading and early death.”
Potential new prostate cancer treatment
Ahsan Arozullah, … early, recurrent hormone-sensitive prostate cancer setting. Astellas is in …
-
Masturbating might slash risk of prostate cancer, claims expert (and more is better!)
24 Apr 2024 12:48 GMT
… ejaculating may help protect against prostate cancer.
Dr Kelly wrote: … Around 12,000 men die every year from the … said they believe the death of ambassador and presenter encouraged … 400 women dying of breast cancer.
It means prostate cancer is behind …
-
EC approves Astellas’ Xtandi for high-risk prostate cancer treatment
24 Apr 2024 11:23 GMT
… ) non-metastatic hormone-sensitive prostate cancer (nmHSPC) who are not … risk of metastasis or death by 57.6% compared … early, recurrent hormone-sensitive prostate cancer setting. Astellas is in … non-metastatic castration-sensitive prostate cancer with BCR at …
-
Frank Field dead at 81 – Ex-Labour MP and peer passes away after prostate cancer battle
24 Apr 2024 06:36 GMT
… Labour MP Frank Field has died, his heartbroken family revealedCredit: … ones this morning announced his death - he was 81.
… dying.
He was put into hospice after being diagnosed with prostate cancer … dying when an MP friend was dying of cancer and wanted to die …
-
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
24 Apr 2024 02:54 GMT
… of their cancer spreading or dying compared to those treated with … their cancer spreading and early death. The patient community welcomes any … 3 will die as a result of their metastatic prostate cancer.6 The …
-
European Commission Approves Astellas' Xtandi For Recurrent Early Prostate Cancer Treatment
24 Apr 2024 01:15 GMT
… recurrent non-metastatic hormone-sensitive prostate cancer who are unsuitable for salvage … the risk of metastasis or death.
The company noted that Xtandi … with non-metastatic castration-sensitive prostate cancer with biochemical recurrent at high …
-
Tributes paid to Glasgow-born 'ceilidh king' Fergie MacDonald after his death
24 Apr 2024 12:06 GMT
Glasgow-born but brought up in Moidart, the renowned button key accordionist is considered to have popularised the West Highland style of traditional Scottish dance music.
He had been undergoing treatment for prostate cancer since 2021.
Born Ferguson …